Journal
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
Volume 38, Issue 3, Pages 751-756Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10815-020-02051-7
Keywords
Ovarian hyperstimulation syndrome (OHSS); Oncofertility; Gonadotropin-releasing hormone (GnRH) antagonist; Long-acting GnRH agonist; GnRH agonist trigger; Lupron depot
Funding
- NIH [K08CA222835, P30CA015704]
Ask authors/readers for more resources
This study reported three cases of severe OHSS among oncofertility patients. Despite measures such as freezing embryos, patients still developed severe symptoms of OHSS. Therefore, caution should be exercised when deciding on treatment strategies for such patients.
Purpose To report three cases of severe ovarian hyperstimulation syndrome (OHSS) among oncofertility patients receiving a long-acting GnRH agonist for ovarian suppression after controlled ovarian hyperstimulation (COH) with a GnRH antagonist protocol Methods Chart abstraction was completed for three patients at a single academic medical center. Patients included were undergoing fertility preservation prior to gonadotoxic chemotherapy. All patients underwent COH with GnRH antagonist protocol and embryo cryopreservation immediately followed by ovarian suppression with long-acting GnRH agonist. Main outcome measure was development of OHSS. Results Despite using GnRH agonist trigger and freezing all embryos, patients developed ascites, intermittent hyponatremia and hemoconcentration consistent with severe early-onset OHSS after receiving long-acting GnRH agonist immediately following oocyte retrieval for ovarian preservation. Conclusions Risk of severe OHSS may be increased when a long-acting GnRH agonist is used for ovarian suppression immediately following oocyte retrieval. A delay in initiating long-acting GnRH agonist after oocyte retrieval in patients at high risk for developing OHSS should be considered.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available